Moore Kuehn Encourages FPRX, SVBI, SOAC, and CAP Investors to Contact Law Firm
News provided by
Share this article
Share this article
NEW YORK, March 5, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:
Five Prime Therapeutics, Inc. (
FPRX)
Five Prime Therapeutics has agreed to be acquired by Amgen. Under the proposed transaction, shareholders of Five Prime will receive $38.00 per share.